Alveolar epithelial cells of lung fibrosis patients are susceptible to severe virus-induced injury.

Alveolar epithelium influenza pulmonary fibrosis senescence senotherapeutic virus

Journal

Clinical science (London, England : 1979)
ISSN: 1470-8736
Titre abrégé: Clin Sci (Lond)
Pays: England
ID NLM: 7905731

Informations de publication

Date de publication:
05 Apr 2024
Historique:
accepted: 05 04 2024
received: 30 01 2024
revised: 02 04 2024
medline: 5 4 2024
pubmed: 5 4 2024
entrez: 5 4 2024
Statut: aheadofprint

Résumé

Patients with pulmonary fibrosis (PF) often experience exacerbations of their disease, characterised by a rapid, severe deterioration in lung function that is associated with high mortality. Whilst the pathobiology of such exacerbations is poorly understood, virus infection is a trigger.  This study investigated virus-induced injury responses of alveolar and bronchial epithelial cells (AECs and BECs respectively) from patients with PF and age-matched controls (Ctrls).  Air liquid interface (ALI) cultures of AECs, comprising type I and II pneumocytes or BECs were inoculated with influenza A virus (H1N1) at 0.1 multiplicity of infection (MOI).  Levels of interleukin-6 (IL-6), IL-36γ and IL-1β were elevated in cultures of AECs from PF patients (PF-AECs, n=8-11), being markedly higher than Ctrl-AECs (n=5-6), 48 h post inoculation (pi) (P<0.05); despite no difference in H1N1 RNA copy numbers 24 h pi.  Furthermore, the virus-induced inflammatory responses of PF-AECs were greater than BECs (from either PF patients or controls), even though viral loads in the BECs were overall 2 to 3-fold higher than AECs.  Baseline levels of the senescence and DNA damage markers, nuclear p21, p16 and H2AXγ were also significantly higher in PF-AECs than Ctrl-AECs and further elevated post-infection.  Senescence induction using etoposide augmented virus-induced injuries in AECs (but not viral load), whereas selected senotherapeutics (rapamycin and mitoTEMPO) were protective.  This study provides evidence that senescence increases the susceptibility of AECs from PF patients to severe virus-induced injury and suggests targeting senescence may provide an alternative option to prevent or treat the exacerbations that worsen the underlying disease.

Identifiants

pubmed: 38577922
pii: 234284
doi: 10.1042/CS20240220
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright 2024 The Author(s).

Auteurs

Jane Read (J)

University of Newcastle, Newcastle, Australia.

Andrew Reid (A)

University of Newcastle, Newcastle, Australia.

Claire Thomson (C)

St Vincent's Hospital Sydney, Sydney, Australia.

Marshall Plit (M)

St Vincent's Hospital Sydney, Sydney, Australia.

Ross Mejia (R)

John Hunter Hospital, Newcastle, Australia.

Darryl A Knight (DA)

Providence Health Care Research Institute, Vancouver, Canada.

Muriel Lize (M)

Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim am Rhein, Germany.

Karim El Kasmi (KE)

Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim am Rhein, Germany.

Christopher Grainge (C)

University of Newcastle, Newcastle, Australia.

Heiko Stahl (H)

Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim am Rhein, Germany.

Michael Schuliga (M)

The University of Newcastle, Newcastle, Australia.

Classifications MeSH